A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice

Overview of attention for article published in Frontiers in immunology, December 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

FUSION PROTEIN COMPRISING ANGPTL3 MONOCLONAL ANTIBODY

Application WO-2024041236-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.